Novo Nordisk Overtakes Luxury Group LVMH as Europe’s Most Valuable Company

LONDON (Reuters) – Danish drugmaker Novo Nordisk unseated LVMH as Europe’s most valuable listed company on Friday, ending the French luxury group’s 2-1/2 year-long reign at the top. Novo Nordisk now has a market capitalisation of $421 billion, according to Refinitiv data. The French-listed LVMH has …